Company Infant Bacterial Therapeutics AB (publ) Other OTC
Equities
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 01/13/01 | |
Maria Ekdahl
DFI | Director of Finance/CFO | 51 | 19/22/19 |
Chief Operating Officer | 57 | 20/14/20 | |
Jonas Rastad
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Agneta Heierson
PRN | Corporate Officer/Principal | - | - |
Leif Gallo
LAW | General Counsel | 65 | - |
Michael Owens
AUD | Comptroller/Controller/Auditor | 68 | 04/15/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Margareta Hagman
BRD | Director/Board Member | 58 | 24/15/24 |
Chairman | 74 | 01/11/01 | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 04/17/04 |
Director/Board Member | 63 | 15/18/15 | |
Eva Idén
BRD | Director/Board Member | 58 | 04/17/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 453,283 | 0 | 0 | 88.04 % |
Stock B | 1 | 13,018,137 | 11,860,512 ( 91.11 %) | 0 |
Company contact information
Infant Bacterial Therapeutics AB
Bryggargatan 10
111 21, Stockholm
+46 7 62 19 37 38
http://www.ibtherapeutics.comGroup companies
Name | Category and Sector |
---|---|
Pharmaceuticals: Major
|
Sector
1st Jan change | Capi. | |
---|---|---|
+14.85% | 7.86TCr | |
+9.32% | 894.18Cr | |
-10.76% | 515.89Cr | |
+54.31% | 484.51Cr | |
+11.19% | 419.11Cr | |
-22.37% | 231.51Cr | |
+11.65% | 228.73Cr | |
-30.09% | 219.11Cr | |
+20.63% | 218.95Cr |